Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 22741 - 22760 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF09) tislelizumab | Tevimbra 100 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 100 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneAUSPtyLtd |
| Australia | (L01FF09) tislelizumab | Tevimbra 100 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 100 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneAUSPtyLtd |
| Australia | (L01FG01) bevacizumab | Abevmy 100 mg/4 mL injection, 4 mL vial | Solution for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | SandozPtyLtd |
Pages
